Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 863 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
10 Мб
Скачать
332
https://t.me/med1917
332
CHAPTER39 Desquamating skin disorders
Introduction todesquamating skin disorders
Also termed exfoliative and necrotizing diseases of the skin. Desquamation of the skin literally means shedding of the skin. In normal physiology des­quamation of the keratinocytes occurs approximately every 14 days. Pathological desquamation involving skin and mucous membranes can cause signicant morbidity and associated complications such as wound infection, sepsis, poor nutrition and pain, synonymous with a major burns patient.
Classification
• Scalded skin syndrome (SSS). Characterized by skin lesions limited to
one mucosal surface
• Stevens Johnson syndrome (SJS). Two or more mucosal surface
involvement in addition to systemic complications and involving less than
10% body surface area
• Toxic epidermal necrolysis (TEN). Amore severe form of SJS aecting
more than 30% body surface area. Between 10% and 30% the condition
is frequently referred as SJS/ TEN
Aetiology
This is an immunological reaction to a foreign antigen. It is usually iatrogenic, mainly involving the use of pharmacological agents. Antimicrobials, anticon­vulsants, analgesics, NSAIDs, and corticosteroids have all been the culprit causing TEN. In addition to drugs viral illnesses have also been reported to cause such an immunological reaction to create SSS and SJS.
https://t.me/med1917
CLINICAL PRESENTATION
Clinical presentation
Signs and symptoms typically seen:
• Apersistent pyrexia
• General malaise
• Cough
• The above may precede dermatological signs by up to 3 weeks
Following general symptoms patients present with generalized tender ery­thema. These progress to bullous eruptions. As the disease progresses vesicles and larger bullae emerge from erythematic areas. Erythema is fol­lowed by epidermolysis.
Nikolsky’s sign is when the epidermis separates on gentle pressure of the skin surface: a sign showing the clinician desquamation of the skin. Sometimes there may be a lag period (1– 3 weeks) from initial immuno­logical insult (ie. administration of a drug) to skin eruption. The dierential characteristics of SSS, SJS, and TEN are summarized in Table 39.1
Table39.1 Clinical characteristics ofdesquamating skin disorders
SSS SJS TEN
Preceding symptoms
Skin lesion distribution
Character of skin lesions
Biopsy features Dermoepidermal
Mucosal involvement
Recovery time 4 weeks 6 weeks 6 weeks
Mortality rate 0% 0– 40% 25– 80%
Adapted with permission from Hawkins HK. The burn problem Apathologist ’s perspective. In Herndon DN (ed.) Total burn care, 4th edn, p.555. Elsevier, Copyright © 2012, Elsevier Inc. All rights reserved.
None Pyrexia, general
Symmetrical, limbs Variable; <10%
Some target lesions Vesicles;
separation with a mononuclear perivascular cell inltrate with target lesions
One surface Two or more Two or more and
malaise
TBSA
Nikolsky’s positive
A more intense dermal inltrate than SSS
Pyrexia, general malaise
Diuse; >30% TBSA
Epidermal detachment; no target lesions; large lesions; Nikolsky’s positive
Minimal dermal inammatory inltrate and large areas of epidermal detachment
severely aected
333
334
https://t.me/med1917
334
CHAPTER39 Desquamating skin disorders
Pathology
A skin biopsy is crucial to identify the severity of the desquamation. The dermal inltrates are made up of immunological cells including cytotoxic T- cells and T- helper cells. Dendritic lymphoid cells are also seen in addition to damaged dermal macrophages and necrotic keratinocytes. As seen in other inammatory skin diseases there is a higher expression of HLA- DR on the keratinocytes. Immunouorescence microscopy will reveal IgM anti­bodies and C3 along the dermoepidermal junction in SJS and TEN. The immune reaction of these disorders is said to be a type II cytotoxic reaction and type IV delayed hypersensitivity reaction.
https://t.me/med1917
PATHOLOGY
335
336
https://t.me/med1917
336
CHAPTER39 Desquamating skin disorders
Management outline
• TEN is a life threatening disease and thus a surgical emergency
• Admission to the burns unit
• Multidisciplinary team (MDT) approach
The role ofthe MDT
• Dermatology. Two punch biopsies to conrm TENS or SJS
• One biopsy in formalin, second in Michael’s medium for
immunouorescence
• Treatments to skin made collaboratively with plastic surgery and
dermatology
• Ophthalmology review early to assess for ocular therapy
• Anaesthesia and ICU teams to be involved at the time of referral or
admission to assess for requirements of intubation
Initial assessment
• Observations 1– 6 hourly including monitoring of airway. Include
standard set of bloods including full blood count, urea and electrolytes, albumin, total protein
• Accurate medical and drug history and involve family and the
patient’s GP
• Precipitating symptoms such as fever, sore throat, conjunctival
symptoms, general malaise
• Commence early analgesic regime
• Liaise with dermatology, may proceed with a skin biopsy
• Liaise with dietician and assess for nasogastric feeding
• Stress ulceration prophylaxis should be started and pulmonary support
may require the input of the anaesthetic or intensivist team
• Corneal involvement can be common and should be managed with
regular saline drops and early involvement of the ophthalmology team
• Assess severity using the SCORTEN scale
• As with major burns, these patients require aggressive uid
resuscitation, additional nutritional support, expert wound care, and a multidisciplinary approach involving physiotherapy, occupational therapy, dietician for nutritional support, and psychology
• Drugs suspicious of causing the reaction should be discontinued
immediately
Further management
• Medical photography
• Daily multidisciplinary review
• Daily dressings to reduce risk of sepsis
• Clinical isolation
• Fluid and electrolyte balance
• Maintain peripheral IV access
• Anticoagulation prophylaxis
https://t.me/med1917
MANAGEMENT OUTLINE
Wound management
• Swabs for microscopy, culture, and sensitivities
• Do not use prophylactic antibiotics as this may increase the risk of
wound sepsis
• Dressings daily and review by the MDT
Surgical approach tomanagement
• Debridement of necrotic epidermal tissue
• Coverage with a biological or synthetic dressings similar to those used in
major burns. Aparticularly good indication for Biobrane
• Debridement of sloughed tissue will reduce the risk of sepsis from
bacterial overgrowth
• Dressings will provide an analgesic eect over the tender
exposed dermis
• In order to reduce bacterial overgrowth topical agents containing silver
nitrate which may be present in dressings
• As these conditions are immunogenic, immunomodulating drugs such as
corticosteroids, cyclosporine A, and intravenous immunoglobulin have
been considered. Their use is controversial and these should not be
commenced until discussion with the transferring or admitting burns unit
337
338
https://t.me/med1917
338
CHAPTER39 Desquamating skin disorders
Prognosis
The SCORTEN system was introduced to predict mortality in patients with TENS and seven signicant factors were identied:
• Age >40years
• Evidence of cancer or haematological malignancy
• Tachycardia >120 beats/ minute
• TBSA involvement at day 1>10%
• Serum urea level >10mmol/ L
• Serum glucose level >14mmol/ L
• Serum bicarbonate level >20mmol/ L
The probability of death is given by the formula: P(death)=e where logit =– 4.448+1.237(SCORTEN) Generally mortality rates are estimated (Table 39.2).
Table39.2 Mortality rates
No of risk factors Mortality rate
0– 1 3.2%
2 12.1%
3 35.3%
4 58.3%
>5 >90%
Adapted from Bastuji- Garin S, et al. SCORTEN: a severity- of- illness score for toxic epidermal necrolysis. Journal of In vestigative Dermatology 2000;155(2):149– 53, Copyright © 2000.
The Society for Investigative Dermatology, Inc., with permission from Elsevier, http:// www. jidonline.org/ article/ S0022- 202X(15)40939- X/ abstract.
logit
/ 1+e
logit
Further reading
Bastuji- Garin S, Fouchard N, Bertocchi M, etal. SCORTEN:a severity- of- illness score for toxic epi-
dermal necrolysis. Journal of Investigative Dermatology 2000;115:149– 53.
Creamer D, Walsh SA, Dziewulski P, et al. U.K. guidelines for the management of Stevens–
Johnson syndrome/ toxic epidermal necrolysis in adults 2016. British Journal of Dermatology 2016;174:1194– 227.
Guillaume JC, Roujeau JC, Revuz J, etal. The culprit drugs in 87 cases of toxic epidermal necrolysis
(Lyell syndrome). Archives of Dermatology 1987;123:1166– 70.
Yetiv J, Bianchini JR, Owens JA. Etiological factors in Stevens- Johnson syndrome. Southern Medical
Journal 1980;73:599– 602.
https://t.me/med1917
Chapter40
339
Military burns
History 340 Epidemiology 340 Causes 340 General management 340 Burn infections 341 Outcomes 341 Prevention 341 Specic causes 1.Explosive weapons 342 Specic causes 2.Incendiary weapons 344 Specic causes 3.Chemical weapons 344 Specic causes 4.Cold burns 345 References 346
340
https://t.me/med1917
340
CHAPTER40 Military burns
History
The concept of a dedicated burn team and unit was established in 1940 by McIndoe at East Grinstead during the Battle of Britain.
Epidemiology
• 5% of all war casualties (troops and civilians) are burns,1 60% are
accidental and 40% combat.2 Combat burns are associated with greater Injury Severity Scores, full thickness burns, and inhalation injury
• Mainly aects young males and exposed areas, eg. face and hands
• The majority are 75% TBSA,4 Up to 25% are >20% total body surface
area (TBSA)
5
Causes
• Explosive weapons (main5). Ordnance devices produce fragments from
the casing, Improvised explosive devices (IEDs) produce fragments from and within the casing and cause more burns
2
• Incendiary weapons, eg. white phosphorous or napalm
• Chemical weapons. Can be lethal (eg. blistering) or incapacitating.
Blistering agents cause burns, eg. mustard gas.
• Radiation or nuclear weapons
• Environment, eg. contact, scald, electrical, cold (frostbite)
General management
During triage >70% TBSA have expectant care, 20– 70% TBSA +/ –
inhalation injury receive early evacuation, and <20% TBSA have delayed hospital care.
• Levels of care include Level IMedical Support within the eld, Level
II Aid Station +/ - surgical capability, Level III Field Hospital oering subspecialty care and Level IV Tertiary Burns Centre in home country. Most soldiers arrive back within 2– 4days
• Resuscitation follows ATLS and EMSB/ ABA guidelines including
warming, IV crystalloid via the Parkland or modied Brooke formula,7 IV antibiotics, and tetanus prophylaxis if associated contaminated battleeld wounds, and analgesia. Blisters are left intact until arrival in a clean environment and wounds are dressed8 During evacuation chemical thromboprophylaxis is given and nasogastric tubes are placed for enteral feeding
• Early escharotomy is considered if deep circumferential burns prior to
transport8 but denitive surgery is performed early (<5days post injury) in the burns centre
6
2
3
3
https://t.me/med1917
Burn infections
• Major organisms include Acinetobacter baumannii >Pseudomonas
aeruginosa >Klebsiella pneumoniae >Staphylococcus aureus. For the
rst 15days Acinetobacter and Staphylococcus predominate. After
15days Pseudomonas and Klebsiella predominate
3
• Topical antimicrobials dressings used include Mafenide acetate
(Sulfamylon), Silver sulfadiazine (eg. Flamazine), silver nitrate solution,
and silver- impregnated dressings (eg. Acticoat). Systemic antibiotics are
given in infected wounds
• Infection associated mortality occurs at higher rates in combat burns.
The main infections causing death include fungus (eg. Aspergillus),
Pseudomonas, and Klebsiella
9
Outcomes
• Gross functional outcomes are good and similar to civilians3 but face and
hand burns can lead to long- term physical and psychological morbidity
• Mortality in military burns at the burn centre is 74%, which is similar
to civilians with same age range.3 The main cause is infection (760%).9
TBSA burn, presence of inhalation injury, ventilator days, and age >
40years are predictors of mortality
Prevention
• Pre- deployment education reduces preventable non- combat burns
• Fire- protective clothing reduces the severity of burn injuries
• Personal protective equipment may reduce penetrating injury
PREVENTION
341
10
Соседние файлы в папке @xirurgi_2025